Search
Search Results
Found 16 items.
-
Human genes in TB infection: their role in immune response
Published: January 26, 20161557PDF: 1071 -
Allergen-specific immunotherapy: an update on immunological mechanisms of action
Published: February 15, 2016832PDF: 543 -
Serial evaluation of antibody titres in patients recovered from COVID-19 and their correlation with disease severity
Published: November 3, 2023637PDF: 57 -
Anti remodeling therapy: new strategies and future perspective in post-ischemic heart failure. Part II
Published: November 24, 20151881PDF: 1322 -
Dose dependence of efficacy but not of safety in sublingual immunotherapy
Published: February 15, 2016833PDF: 454 -
Anti remodeling therapy: new strategies and future perspective in post-ischemic heart failure: Part I
Published: November 24, 20151573PDF: 1126 -
Programmed cell death-ligand 1 expression and CD8 positive tumor-infiltrating lymphocyte density in non-small cell lung carcinoma and its association with histopathological grading
Published: February 21, 2025396PDF_EARLY VIEW: 111 -
Sex hormones and COVID-19: tussle between the two
Published: September 18, 2020197303PDF: 4595 -
Gender differences in vaccine therapy: where are we in COVID-19 pandemic?
Published: April 8, 20219106PDF: 2326 -
Coeliac and cardiovascular disease: a possible relationship between two apparently separate conditions
Published: July 20, 20221562PDF: 631 -
Tuberculosis endemicity and BCG vaccination: Protection against COVID-19
Published: June 24, 20221038PDF: 295 -
Incidental diagnosis of lung adenocarcinoma following coronavirus OC 43 severe pneumonia
Published: July 14, 20201368PDF: 579 -
Point-of-care test for tuberculosis: a boon in diagnosis
Published: April 28, 20232355PDF: 905 -
Subtyping of advanced lung cancer based on PD-L1 expression, tumor histopathology and mutation burden (EGFR and KRAS): a study from North India
Published: February 1, 20231346PDF: 347 -
Latent tuberculosis diagnostics: current scenario and review
Published: May 3, 20241144PDF_EARLY VIEW: 534 -
Complete response to pembrolizumab as a single agent in a patient with stage III NSCLC with high PD-L1 expression: a case report
Published: November 25, 20221438PDF: 350
1 - 16 of 16 items